www.fdanews.com/articles/130834-akebia-completes-single-dose-phase-iia-trial-of-oral-anemia-drug

Akebia Completes Single-Dose Phase IIa Trial of Oral Anemia Drug

October 6, 2010

Akebia Therapeutics Inc. has successfully completed a Phase 2a trial of its orally administered anti-anemia drug for kidney disease patients.
MedCity News